B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Recall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B ...

BHUBANESWAR: Ananta Mahakud had always envisioned a bright future for his only daughter Truptimayee. His dreams came crashing ...

The company plans to use the Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment ...

Dozens of victims of Tropical Storm Helene find Red Cross shelter at A-B Tech a boost to morale, appreciate the care provided ...

A 57-year-old woman with a 12-h history of fever and severe pain in her back, pelvis, and thighs attended our hospital. 24 h ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease and has raised £63.5 million ...

The Liberal and Green Parties both tackled improving cell service in announcements Tuesday, but for different reasons. Meanwhile, the Progressive Conservatives threatened to sue the federal government ...